Neurodegenerative
diseases such as Alzheimer’s disease (AD)
are associated with progressive neuronal cell death, and they are
commonly correlated with aberrant protein misfolding and aggregation
of Aβ peptides. Transition metal ions (Cu, Fe, and Zn) have
been shown to promote aggregation and oxidative stress through formation
of Aβ–metal complexes. In this context, integrating molecular
scaffolds rationally is used here to generate multifunctional molecules
as modulators for metal-induced abnormalities. This work encompasses
two azo-stilbene (AS)-derived compounds (AS-HL1 and AS-HL2), the rationale behind the design, their
synthesis, characterization, and metal chelation ability [Cu(II) and
Zn(II)]. The molecular frameworks of the designed compounds consist
of stilbene as an Aβ-interacting moiety, whereas N,N,O and N,N,N,O
donor atoms are linked to generate the metal chelation moiety. Furthermore,
we went on exploring their multifunctionality with respect to (w.r.t.)
(i) their metal chelating capacities and (ii) their utility to modulate
the aggregation pathways of both metal-free and metal-bound amyloid-β,
(iii) scavenge free radicals, and (iv) inhibit the activity of acetylcholinesterase
and (v) cytotoxicity. Moreover, the compounds were able to sequester
Cu2+ from the Aβ–Cu complex as studied by
the UV–visible spectroscopic assay. Molecular docking studies
were also performed with Aβ and acetylcholinesterase enzyme.
Overall, the studies presented here qualify these molecules as promising
candidates for further investigation in the quest for finding a treatment
for Alzheimer’s disease.